Mobile Menu

Genomics week in brief: Week ending 23rd October

Another week of jam-packed news and research summarised for you in your latest Genomics Week in Brief – enjoy!

Top stories from the past week

  • Scientists have reported encouraging early results of a gene therapy strategy against Angelman syndrome, a neurodevelopmental disorder. (Judson et al, 2021)
  • A new study has revealed a specific molecular mechanism that controls the transition from acute to chronic pain. (Fotio et al, 2021)
  • Researchers have developed a new tool called Repair-seq that reveals in exquisite detail how genome editing tools work. (Hussmann et al, 2021)
  • New findings have revealed that Black women are more likely to experience barriers to genetic counselling and testing. (Ademuyiwa et al, 2021)
  • An international team has shown that an improved immune response can be passed on to offspring in mice. (Katzmarski et al, 2021)
  • Researchers have identified key genetic factors that are important for the efficacy of radiation and chemotherapy. (Jiang et al, 2021)
  • A recent genomic study has revealed new causative variants among diverse populations with inherited retinal disease. (Biswas et al, 2021)
  • A new study has added previously uncharacterised viral genomes and genes to the pool of human gut viromes. (Espen et al, 2021)
  • Researchers have found a gene that prevents excessive weight gain and diabetes during high-fat diets in mice. (Kaare et al, 2021)
  • A new deep-learning algorithm has been found to detect genetic mutations and DNA mismatch repair deficiency in colorectal cancers more efficiently. (Bilal et al, 2021)
  • Researchers have highlighted that our genes may play an unexpected role in pro-conservation sentiment. (Chang et al, 2021)
  • New DNA research has shown that humans did not cause woolly mammoths to go extinct, it was in fact climate change. (Wang et al, 2021)
  • Scientists have shown that cell-free DNA from cerebrospinal fluid can be used to detect measurable residual disease in children treated for medulloblastoma. (Liu et al, 2021)

In other news

  • Sanaria Inc. and Seattle Children’s Research Institute have announced their collaboration for the development of genetically attenuated malaria vaccines. (Sanaria, 2021)
  • The Cellular Senescence Network (SenNet) Program announced it will award $125 million to 16 teams that form the new SenNet Consortium. The overall goal is to build an atlas of cellular senescence. (UPMC, 2021)

Image credit: canva

More on these topics

Gene Therapy / Genomics / Week in brief